Cargando…

The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease

BACKGROUND: Several randomised clinical trials (RCTs) performing faecal microbiota transplantation (FMT) for the management of inflammatory bowel disease (IBD), particularly for ulcerative colitis, have recently been published, but with major variations in study design. These include differences in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lopetuso, Loris Riccardo, Deleu, Sara, Godny, Lihi, Petito, Valentina, Puca, Pierluigi, Facciotti, Federica, Sokol, Harry, Ianiro, Gianluca, Masucci, Luca, Abreu, Maria, Dotan, Iris, Costello, Samuel Paul, Hart, Ailsa, Iqbal, Tariq H, Paramsothy, Sudarshan, Sanguinetti, Maurizio, Danese, Silvio, Tilg, Herbert, Cominelli, Fabio, Pizarro, Theresa T, Armuzzi, Alessandro, Cammarota, Giovanni, Gasbarrini, Antonio, Vermeire, Séverine, Scaldaferri, Franco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Guideline
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423477/ https://www.ncbi.nlm.nih.gov/pubmed/37339849 http://dx.doi.org/10.1136/gutjnl-2023-329948

Ejemplares similares

Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2023)

Bariatric procedures and microbiota: patient selection and outcome prediction
por: Puca, Pierluigi, et al.
Publicado: (2021)

Fecal Microbiota Transplantation in Inflammatory Bowel Disease: Beyond the Excitement
por: Ianiro, Gianluca, et al.
Publicado: (2014)

Pre- and Posttherapy Assessment of Intestinal Soluble Mediators in IBD: Where We Stand and Future Perspectives
por: Scaldaferri, F., et al.
Publicado: (2013)

Role of Microbiota and Innate Immunity in Recurrent Clostridium difficile Infection
por: Bibbò, Stefano, et al.
Publicado: (2014)

The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2020)

European consensus conference on faecal microbiota transplantation in clinical practice
por: Cammarota, Giovanni, et al.
Publicado: (2017)

International consensus conference on stool banking for faecal microbiota transplantation in clinical practice
por: Cammarota, Giovanni, et al.
Publicado: (2019)

Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study
por: Ianiro, Gianluca, et al.
Publicado: (2020)

The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease
por: Holleran, Grainne, et al.
Publicado: (2017)

Bacillus clausii for the Treatment of Acute Diarrhea in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Ianiro, Gianluca, et al.
Publicado: (2018)

Commensal Clostridia: leading players in the maintenance of gut homeostasis
por: Lopetuso, Loris R, et al.
Publicado: (2013)

Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center
por: Ianiro, Gianluca, et al.
Publicado: (2021)

Avoiding food avoidance in patients with inflammatory bowel disease
por: Godny, Lihi, et al.
Publicado: (2023)

Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel
por: Ianiro, Gianluca, et al.
Publicado: (2020)

The Influence of Helicobacter pylori on Human Gastric and Gut Microbiota
por: Fiorani, Marcello, et al.
Publicado: (2023)

Fecal Microbiota Transplantation: Screening and Selection to Choose the Optimal Donor
por: Bibbò, Stefano, et al.
Publicado: (2020)

Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma
por: Ianiro, Gianluca, et al.
Publicado: (2020)

Gut microbiota and immunotherapy of renal cell carcinoma
por: Bibbò, Stefano, et al.
Publicado: (2023)

Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center
por: Scaldaferri, Franco, et al.
Publicado: (2023)

Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab
por: Scaldaferri, Franco, et al.
Publicado: (2017)

Gut–Joint Axis: The Role of Physical Exercise on Gut Microbiota Modulation in Older People with Osteoarthritis
por: de Sire, Alessandro, et al.
Publicado: (2020)

Bacteriocins and Bacteriophages: Therapeutic Weapons for Gastrointestinal Diseases?
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2019)

Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis
por: Di Vincenzo, Federica, et al.
Publicado: (2022)

Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition
por: Rinninella, Emanuele, et al.
Publicado: (2019)

Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic
por: Ianiro, Gianluca, et al.
Publicado: (2020)

Gut Microbiota during Dietary Restrictions: New Insights in Non-Communicable Diseases
por: Rinninella, Emanuele, et al.
Publicado: (2020)

The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer
por: Cianci, Rossella, et al.
Publicado: (2019)

Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches
por: Privitera, Giuseppe, et al.
Publicado: (2021)

Dietary Magnesium Alleviates Experimental Murine Colitis through Modulation of Gut Microbiota
por: Del Chierico, Federica, et al.
Publicado: (2021)

Orphan patients with inflammatory bowel disease - when we treat beyond evidence
por: Privitera, Giuseppe, et al.
Publicado: (2021)

Gut Microbial Flora, Prebiotics, and Probiotics in IBD: Their Current Usage and Utility
por: Scaldaferri, Franco, et al.
Publicado: (2013)

Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel
por: Ianiro, Gianluca, et al.
Publicado: (2022)

Future Modulation of Gut Microbiota: From Eubiotics to FMT, Engineered Bacteria, and Phage Therapy
por: Airola, Carlo, et al.
Publicado: (2023)

Microbiota Composition in Diverticular Disease: Implications for Therapy
por: Tursi, Antonio, et al.
Publicado: (2022)

Nutrition, IBD and Gut Microbiota: A Review
por: Mentella, Maria Chiara, et al.
Publicado: (2020)

Infliximab does not increase colonic cancer risk associated to murine chronic colitis
por: Lopetuso, Loris R, et al.
Publicado: (2016)

“Bacterial Consortium”: A Potential Evolution of Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection
por: Quaranta, Gianluca, et al.
Publicado: (2022)

The human gut microbiota and virome: Potential therapeutic implications
por: Scarpellini, Emidio, et al.
Publicado: (2015)

Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7q7ie1scdc1uqonghjm8ilju4g